HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
Abstract Background The clinical treatment of ovarian cancer with ascites is problematic. The main reasons for treatment failure are the susceptibility to intraperitoneal metastasis and chemotherapeutic drug resistance. The purpose and significance of this study is to evaluate which marker might eva...
Main Authors: | Duanyang Liu, Dan Kong, Jing Li, Lei Gao, Di Wu, Yu Liu, Weiwei Yang, Lei Zhang, Jiang Zhu, Xiaoming Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13048-018-0402-3 |
Similar Items
-
Ovarian hyperstimulation syndrome and pregnancy luteoma mimicking malignant ascites: a rare case report
by: Jing Chen, et al.
Published: (2023-05-01) -
The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
by: Zheng Li-e, et al.
Published: (2016-01-01) -
Meigs syndrome caused by fibrothecoma of the ovary
by: Shih-Ting Huang, et al.
Published: (2023-01-01) -
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
by: Vincent Dochez, et al.
Published: (2019-03-01) -
Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
by: Elham Saffarieh, et al.
Published: (2022-08-01)